Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment

Completed · Phase 4

Conditions studied: Metabolic Syndrome

In brief

To determine whether the combination of ezetimibe and simvastatin improves biomarkers of atherothrombosis compared to simvastatin alone in patients with the metabolic syndrome.

Key facts

Study ID
NCT00819403
Run by
University of Maryland, Baltimore
People needed
15
Starts
2009-01-01
Expected to finish
2011-11-01
Last updated by the study team
2020-01-14

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.